161 related articles for article (PubMed ID: 7173181)
1. Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.
Appelbaum PC; Tamim J; Stavitz J; Aber RC; Pankuch GA
Eur J Clin Microbiol; 1982 Jun; 1(3):159-65. PubMed ID: 7173181
[TBL] [Abstract][Full Text] [Related]
2. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Braveny I; Machka K; Elsser R
Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Verbist L; Verhaegen J
Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844
[TBL] [Abstract][Full Text] [Related]
5. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].
Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E
Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
8. Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.
Hoffman TA; Cleary TJ; Bercuson DH
J Antibiot (Tokyo); 1981 Oct; 34(10):1334-40. PubMed ID: 6796556
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
Dibb WL; Asphaug Kjellevold V; Digranes A
Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
[TBL] [Abstract][Full Text] [Related]
10. Comparative activities of 13 beta-lactam antibiotics.
Muytjens HL; van der Ros-van de Repe J
Antimicrob Agents Chemother; 1982 Jun; 21(6):925-34. PubMed ID: 7114839
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
Rolfe RD; Finegold SM
Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
[TBL] [Abstract][Full Text] [Related]
12. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Prince AS; Neu HC
Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Miller MA; LeFrock JL; Vercler MJ
Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
Horadam VW; Smilack JD; Montgomery CL; Werringloer J
Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
[TBL] [Abstract][Full Text] [Related]
15. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH
Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections.
Ohm-Smith MJ; Hadley WK; Sweet RL
Antimicrob Agents Chemother; 1982 Oct; 22(4):711-4. PubMed ID: 7181484
[TBL] [Abstract][Full Text] [Related]
18. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
Digranes A; Dibb WL; Benonisen E
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
[TBL] [Abstract][Full Text] [Related]
19. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli.
Strandberg DA; Jorgensen JH; Drutz DJ
Antimicrob Agents Chemother; 1983 Aug; 24(2):282-6. PubMed ID: 6685453
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
O'Donnell ED; Freimer EH; Gilardi GL; Raeder R
Antimicrob Agents Chemother; 1982 Apr; 21(4):673-5. PubMed ID: 6211143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
